Assessing weight change of risperidone long - acting injectable treatment in dual diagnosis patients

被引：0
作者：
Natan, Z. [1 ]
Gimelfarb, Y. [1 ]
Kaikov, E. [1 ]
机构：
[1] Abarbanel Mental Hlth Ctr, Bat Yam, Israel
来源：
EUROPEAN PSYCHIATRY | 2008年 / 23卷
关键词：
D O I：
10.1016/j.eurpsy.2008.01.953
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S165 / S165
页数：1
相关论文
共 50 条
  • [41] Long-acting injectable risperidone for control of agitation in dementia
    Yumru, Mehmet
    Ozren, Murat Eren
    Savas, Haluk A.
    Selek, Salih
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (10) : 1651 - 1652
  • [42] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L
    Lam, A
    McCormick, J
    Luong, D
    Camacho, F
    VALUE IN HEALTH, 2005, 8 (06) : A202 - A203
  • [43] Cognitive improvements in patients with schizophrenia with risperidone long-acting injectable: Relationship to functioning?
    Pandina, G
    Bilder, R
    Harvey, P
    Lasser, RA
    Rodriguez, S
    Turkoz, I
    Gharabawi, G
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 500 - 500
  • [44] Treatment adherence in schizophrenia using risperidone long-acting injectable: as early as possible, as long as possible
    Viala, A.
    Boulicot, V.
    Merlot, A.
    Pinede, D.
    Vacheron, M. N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S516 - S517
  • [45] Initial dosing strategies for long-acting injectable risperidone
    Viner, Mark W.
    Matuszak, Jeremy M.
    Knight, Linda J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (08) : 1310 - 1311
  • [46] Neurocognition and attitudes to medication in risperidone long-acting injectable
    Penades, R.
    Catalan, R.
    Pujol, N.
    Navarro, V.
    Massana, G.
    Gasto, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S462 - S463
  • [47] Clinical review of a long-acting, injectable formulation of risperidone
    Knox, ED
    Stimmel, GL
    CLINICAL THERAPEUTICS, 2004, 26 (12) : 1994 - 2002
  • [48] Direct treatment change to risperidone long-acting injectable led to improved efficacy and safety in the Dutch subgroup of the StoRMi trial
    Arnoldussen, WJ
    Teijeiro, R
    Hoekstra, R
    Janssen, H
    Melman, C
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S229 - S229
  • [49] Satisfaction of patients and caregivers with long-acting injectable risperidone and oral atypical antipsychotics
    Han, CS
    Lee, BH
    Kim, YK
    Lee, HJ
    Kim, SH
    Kim, L
    Lee, MS
    Joe, SH
    Ham, BJ
    Jung, IK
    PRIMARY CARE & COMMUNITY PSYCHIATRY, 2005, 10 (03) : 119 - 124
  • [50] Service utilisation of schizophrenic patients treated with long-acting injectable risperidone in Taiwan
    Chang, H.
    Su, K.
    McCropne, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S446 - S447
12345